<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2500-5006</journal-id>
<journal-title><![CDATA[Revista Colombiana de Nefrología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colom. nefrol.]]></abbrev-journal-title>
<issn>2500-5006</issn>
<publisher>
<publisher-name><![CDATA[Asociación Colombiana de Nefrología e Hipertensión Arterial]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2500-50062022000100402</article-id>
<article-id pub-id-type="doi">10.22265/acnef.9.1.526</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Crisis renal esclerodérmica]]></article-title>
<article-title xml:lang="en"><![CDATA[Sclerodermic renal crisis]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pedroza Pallares]]></surname>
<given-names><![CDATA[Álvaro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castiglioni]]></surname>
<given-names><![CDATA[Teresa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bouza]]></surname>
<given-names><![CDATA[Gabriel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Sanatorio de los Arcos Servicio de Medicina Interna ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Argentina</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Centro de Patología Servicio Anatomía Patológica ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Argentina</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Sanatorio de los Arcos Jefe de Servicio Medicina Interna ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Argentina</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2022</year>
</pub-date>
<volume>9</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S2500-50062022000100402&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S2500-50062022000100402&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S2500-50062022000100402&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La esclerosis sistémica (ES) es una enfermedad inmunomediada, caracterizada por la presencia de fibrosis e inflamación tisular, que conlleva a cambios degenerativos vasculares de la piel y órganos internos tales como pulmón, corazón, tracto gastrointestinal y riñón. Tiene formas de presentación localizadas y sistémicas. La crisis renal esclerodérmica (CRE) es la manifestación grave en el riñón que se caracteriza por: a) hipertensión maligna, de inicio súbito asociado a aumento de actividad de renina plasmática. Hay una variante clínica que cursa con normotensión, la cual es de peor pronóstico; b) insuficiencia renal aguda (IRA); c) microangiopatía trombótica. A continuación, se relata la presentación de un caso de CRE en un paciente de sexo femenino de 60 años, que ingresó a la Institución con un cuadro caracterizado por crisis hipertensiva tipo emergencia, caída de filtrado glomerular severa, microhematuria y proteinuria; la cual recibió tratamiento médico, pero por persistencia de signos y síntomas, se decidió realizar una punción biopsia renal, la cual confirmo el diagnóstico.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Systemic sclerosis (SS) is characterized by the presence of thickening and hardening of the skin (from the Greek "sclero"), it has forms of limited and diffuse manifestation. It is chronic in pattern and manifests with vascular dysfunction and severe systemic connective fibrosis. Sclerodermic renal crisis (CRE) is the severe manifestation in the kidney, and is characterized by: a) Malignant hypertension, of sudden onset associated with increased plasma renin activity. There is a clinical variant, which presents with normotension, which has a worse prognosis. (UTAH); b) Acute Renal Failure (ARF); c) Proteinuria in the non-nephrotic range. Microscopic hematuria and casts are uncommon. Next, we are going to report the presentation of a case of sclerodermic renal crisis (CRE), in a 60-year-old female patient, who was admitted to our institution with a condition characterized by severe arterial hypertension, severe glomerular filtration drop, microhematuria and proteinuria; which received medical treatment, but due to the persistence of signs and symptoms, it was decided to perform a renal biopsy puncture, which confirmed the diagnosis.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[insuficiencia renal aguda]]></kwd>
<kwd lng="es"><![CDATA[esclerosis sistémica]]></kwd>
<kwd lng="es"><![CDATA[inhibidores enzima convertidora de angiotensina]]></kwd>
<kwd lng="es"><![CDATA[hipertensión.]]></kwd>
<kwd lng="en"><![CDATA[Acute renal failure]]></kwd>
<kwd lng="en"><![CDATA[systemic sclerosis]]></kwd>
<kwd lng="en"><![CDATA[angiotensin converting enzyme inhibitors]]></kwd>
<kwd lng="en"><![CDATA[hypertension.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guillevin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bérezné]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Seror]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pourrat]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mahr]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls]]></article-title>
<source><![CDATA[Rheumatology]]></source>
<year>2012</year>
<volume>51</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>460-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mouthon]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bérezné]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bussone]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Noël]]></surname>
<given-names><![CDATA[L-H]]></given-names>
</name>
<name>
<surname><![CDATA[Villiger]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Guillevin]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis]]></article-title>
<source><![CDATA[Clin Rev Allergy Immunol.]]></source>
<year>2011</year>
<volume>40</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>84-91</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abbott]]></surname>
<given-names><![CDATA[KC]]></given-names>
</name>
<name>
<surname><![CDATA[Trespalacios]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[Welch]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
<name>
<surname><![CDATA[Agodoa]]></surname>
<given-names><![CDATA[LYC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scleroderma at end stage renal disease in the United States: patient characteristics and survival]]></article-title>
<source><![CDATA[J Nephrol]]></source>
<year>2002</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>236-40</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Penn]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Howie]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kingdon]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bunn]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Stratton]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Black]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scleroderma renal crisis: patient characteristics and long-term outcomes]]></article-title>
<source><![CDATA[QJM Int J Med]]></source>
<year>2007</year>
<volume>100</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>485-94</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alenzi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scleroderma renal crisis: Importance of knowing and differentiating in emergency unit]]></article-title>
<source><![CDATA[International Journal of Clinical Rheumatology]]></source>
<year>2019</year>
<volume>14</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>3</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trimarchi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Calvo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Malvar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alberton]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Lococo]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Greloni]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Enfermedades Glomerulares]]></source>
<year>2017</year>
<page-range>616-21</page-range><publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[El Edén del Hipocampo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steen]]></surname>
<given-names><![CDATA[VD]]></given-names>
</name>
<name>
<surname><![CDATA[Costantino]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Shapiro]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Medsger]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcome of Renal Crisis in Systemic Sclerosis: Relation to Availability of Angiotensin Converting Enzyme (ACE) Inhibitors]]></article-title>
<source><![CDATA[Ann Intern Med.]]></source>
<year>1990</year>
<volume>113</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>352-7</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cannon]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hassar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Case]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
<name>
<surname><![CDATA[Casarella]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sommers]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[LeROY]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[THE RELATIONSHIP OF HYPERTENSION AND RENAL FAILURE IN SCLERODERMA (PROGRESSIVE SYSTEMIC SCLEROSIS) TO STRUCTURAL AND FUNCTIONAL ABNORMALITIES OF THE RENAL CORTICAL CIRCULATION]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>1974</year>
<volume>53</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-46</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Donohoe]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scleroderma and the kidney]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>1992</year>
<volume>41</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>462-77</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steen]]></surname>
<given-names><![CDATA[VD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scleroderma renal crisis]]></article-title>
<source><![CDATA[Rheum Dis Clin North Am]]></source>
<year>2003</year>
<volume>29</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>315-33</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Woodworth]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Furst]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Timely renal transplantation for scleroderma end-stage kidney disease patients can improve outcomes and quality of life]]></article-title>
<source><![CDATA[Ann Transl Med]]></source>
<year>2019</year>
<volume>7</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>22</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="">
<source><![CDATA[Afección renal en la esclerosis sistémica]]></source>
<year></year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
